Literature DB >> 29395371

ASPEN-AND-ESPEN: A postacute-care comparison of the basic definition of malnutrition from the American Society of Parenteral and Enteral Nutrition and Academy of Nutrition and Dietetics with the European Society for Clinical Nutrition and Metabolism definition.

Dolores Sánchez-Rodríguez1, Ester Marco2, Natalia Ronquillo-Moreno3, Liev Maciel-Bravo3, Abel Gonzales-Carhuancho4, Xavier Duran5, Anna Guillén-Solà6, Olga Vázquez-Ibar7, Ferran Escalada6, Josep M Muniesa6.   

Abstract

BACKGROUND: The aim of this study was to assess the prevalence of malnutrition by applying the ASPEN/AND definition and the ESPEN consensus definition in a postacute-care population, and secondly, to determine the metrological properties of the set of six clinical characteristics that constitute the ASPEN/AND basic diagnosis, compared to the ESPEN consensus, based mostly on objective anthropometric measurements.
METHODS: Prospective study of 84 consecutive deconditioned older inpatients (85.4 ± 6.2; 59.5% women) admitted for rehabilitation in postacute care. ASPEN/AND diagnosis of malnutrition was considered in presence of at least two of the following: low energy intake, fluid accumulation, diminished handgrip strength, and loss of weight, muscle mass, or subcutaneous fat. Sensitivity, specificity, positive and negative predictive values, accuracy, likelihood ratios, and kappa statistics were calculated for ASPEN/AND criteria and compared with ESPEN consensus.
RESULTS: The prevalence of malnutrition by ASPEN/AND criteria was 63.1% and by ESPEN consensus, 20.2%; both diagnoses were associated with significantly longer length of stay, but the ESPEN definition was significantly associated with poorer functional outcomes after the rehabilitation program. Compared to ESPEN consensus, ASPEN/AND diagnosis showed fair validity (sensitivity = 94.1%; specificity = 44.8%); kappa statistic was 2.217.
CONCLUSIONS: Applying the ASPEN/AND definition obtained a higher prevalence of malnutrition in a postacute-care population than was identified by the ESPEN definition. ASPEN/AND criteria had fair validity and agreement compared with the ESPEN definition. A simple, evidence-based, unified malnutrition definition might improve geriatric care.
Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  ASPEN/AND; ESPEN; Malnutrition; Older people; Postacute

Mesh:

Year:  2018        PMID: 29395371     DOI: 10.1016/j.clnu.2018.01.017

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  11 in total

1.  Normalized measures and patient characteristics to identify undernutrition in infants and young children treated for cancer.

Authors:  Daniel V Runco; Karen Wasilewski-Masker; Courtney E McCracken; Martha Wetzel; Claire M Mazewski; Briana C Patterson; Ann C Mertens
Journal:  Clin Nutr ESPEN       Date:  2020-06-02

2.  Consensus on the standard terminology used in the nutrition care of adult patients with chronic kidney disease.

Authors:  Cristina Martins; Simone L Saeki; Marcelo Mazza do Nascimento; Fernando M Lucas Júnior; Ana Maria Vavruk; Christiane L Meireles; Sandra Justino; Denise Mafra; Estela Iraci Rabito; Maria Eliana Madalozzo Schieferdecker; Letícia Fuganti Campos; Denise P J van Aanholt; Ana Adélia Hordonho; Marcia Samia Pinheiro Fidelix
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

3.  Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer.

Authors:  Liangyu Yin; Jie Liu; Xin Lin; Na Li; Jing Guo; Yang Fan; Ling Zhang; Muli Shi; Hongmei Zhang; Xiao Chen; Chang Wang; Li Deng; Wei Li; Zhenming Fu; Chunhua Song; Zengqing Guo; Jiuwei Cui; Hanping Shi; Hongxia Xu
Journal:  Eur J Clin Nutr       Date:  2021-01-18       Impact factor: 4.884

Review 4.  Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer.

Authors:  Delky Meza-Valderrama; Ester Marco; Vanesa Dávalos-Yerovi; Maria Dolors Muns; Marta Tejero-Sánchez; Esther Duarte; Dolores Sánchez-Rodríguez
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

5.  Prevalence and Associated Factors of Coexistence of Malnutrition and Sarcopenia in Geriatric Rehabilitation.

Authors:  Shinta Nishioka; Tatsuya Matsushita; Anna Yamanouchi; Yuka Okazaki; Kana Oishi; Emi Nishioka; Natsumi Mori; Yoshiharu Tokunaga; Shinya Onizuka
Journal:  Nutrients       Date:  2021-10-23       Impact factor: 5.717

Review 6.  Malnutrition in Hospitalized Old Patients: Screening and Diagnosis, Clinical Outcomes, and Management.

Authors:  Francesco Bellanti; Aurelio Lo Buglio; Stefano Quiete; Gianluigi Vendemiale
Journal:  Nutrients       Date:  2022-02-21       Impact factor: 5.717

7.  Features Associated With Weight Loss and Growth Stunting for Young Children During Cancer Therapy.

Authors:  Daniel V Runco; Karen Wasilewski-Masker; Claire M Mazewski; Briana C Patterson; Ann C Mertens
Journal:  J Pediatr Hematol Oncol       Date:  2021-11-01       Impact factor: 1.170

8.  Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study.

Authors:  Dolores Sanchez-Rodriguez; Médéa Locquet; Jean-Yves Reginster; Etienne Cavalier; Olivier Bruyère; Charlotte Beaudart
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-07-13       Impact factor: 12.910

Review 9.  Malnutrition and its effects in severely injured trauma patients.

Authors:  Suzan Dijkink; Karien Meier; Pieta Krijnen; D Dante Yeh; George C Velmahos; Inger B Schipper
Journal:  Eur J Trauma Emerg Surg       Date:  2020-01-23       Impact factor: 3.693

10.  Obesity and Heath-Carter Somatotyping of 3438 Adults in the Xinjiang Uygur Autonomous Region of China by Multivariate Analysis.

Authors:  Guochang Xu; Guojian Zhou; Quanying Qu; Ying Hu; Yueriguli Saitierding; Maierdanjang Mohetaer; Yeerkenbieke Buerlan; Xuejun Zhong; Huanjiu Xi; Xiaoyuan Liu; Wenhui Li; Youfeng Wen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-15       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.